Oxidative stress induces nuclear translocation of C-terminus of alpha-synuclein in dopaminergic cells.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Biochemical and Biophysical Research Communications - BBRC

• Publication date

  2006-03-31

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1016/J.BBRC.2006.01.148PMID 16480958
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• [Effect of repeated acute hypoxic treatment on the expression of alpha-synuclein in the mouse brain cortex].

  2004cited by this paper
• Nuclear Localization of α-Synuclein and Its Interaction with Histones†

  2003cited by this paper
• Alpha-synuclein aggregation and neurodegenerative diseases.

  2003cited by this paper
• Parkin Cleaves Intracellular α-Synuclein Inclusions via the Activation of Calpain*

  2003cited by this paper
• Effects of Oxidative and Nitrative Challenges on α-Synuclein Fibrillogenesis Involve Distinct Mechanisms of Protein Modifications*

  2003cited by this paper
• α‐Synuclein protects naive but not dbcAMP‐treated dopaminergic cell types from 1‐methyl‐4‐phenylpyridinium toxicity

  2003cited by this paper
• Nuclear localization of alpha-synuclein and its interaction with histones.

  2003cited by this paper
• Distinct cleavage patterns of normal and pathologic forms of alpha-synuclein by calpain I in vitro.

  2003cited by this paper
• Distinct cleavage patterns of normal and pathologic forms of α‐synuclein by calpain I in vitro

  2003cited by this paper
• α-Synuclein aggregation and neurodegenerative diseases

  2003cited by this paper
• Parkin cleaves intracellular alpha-synuclein inclusions via the activation of calpain.

  2003cited by this paper
• α-Synuclein Lowers p53-dependent Apoptotic Response of Neuronal Cells

  2002cited by this paper
• Calpain activation after mitochondrial permeability transition in microcystin-induced cell death in rat hepatocytes.

  2002cited by this paper
• Deferoxamine Attenuates Iron-Induced Oxidative Stress and Prevents Mitochondrial Aggregation and α-Synuclein Translocation in SK-N-SH Cells in Culture

  2002cited by this paper
• Tubulin seeds alpha-synuclein fibril formation.

  2002cited by this paper
• Alpha-synuclein lowers p53-dependent apoptotic response of neuronal cells. Abolishment by 6-hydroxydopamine and implication for Parkinson's disease.

  2002cited by this paper
• Tubulin Seeds α-Synuclein Fibril Formation*

  2002cited by this paper
• Limited proteolysis of NACP/α-synuclein

  2001cited by this paper
• Muscarinic Receptor Stimulation Induces Translocation of an α-Synuclein Oligomer from Plasma Membrane to a Light Vesicle Fraction in Cytoplasm*

  2001cited by this paper
• Limited proteolysis of NACP/alpha-synuclein.

  2001cited by this paper
• α-Synuclein and the Parkinson's disease-related mutant Ala53Thr-α-synuclein do not undergo proteasomal degradation in HEK293 and neuronal cells

  2000cited by this paper
• In situ and in vitro study of colocalization and segregation of alpha-synuclein, ubiquitin, and lipids in Lewy bodies.

  2000cited by this paper
• α‐Synuclein Up‐Regulation in Substantia Nigra Dopaminergic Neurons Following Administration of the Parkinsonian Toxin MPTP

  2000cited by this paper
• alpha-synuclein promotes mitochondrial deficit and oxidative stress.

  2000cited by this paper
• Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders.

  2000cited by this paper
• α-Synuclein Promotes Mitochondrial Deficit and Oxidative Stress

  2000cited by this paper
• Alpha-synuclein and the Parkinson's disease-related mutant Ala53Thr-alpha-synuclein do not undergo proteasomal degradation in HEK293 and neuronal cells.

  2000cited by this paper
• Oxidative stress induces amyloid-like aggregate formation of NACP/α-synuclein in vitro

  1999cited by this paper
• Oxidative stress induces amyloid-like aggregate formation of NACP/alpha-synuclein in vitro.

  1999cited by this paper
• Immunoelectron-microscopic demonstration of NACP/alpha-synuclein-epitopes on the filamentous component of Lewy bodies in Parkinson's disease and in dementia with Lewy bodies.

  1998cited by this paper
• Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease.

  1993cited by this paper
• A novel N18TG2 x mesencephalon cell hybrid expresses properties that suggest a dopaminergic cell line of substantia nigra origin

  1992cited by this paper
• Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal

  1988cited by this paper

• Alpha-synuclein and RNA viruses: Exploring the neuronal nexus.

  2024cites this paper
• Special Issue “Neurobiology of Protein Synuclein”

  2024cites this paper
• Neurodegenerative disease: New hopes and perspectives.

  2023cites this paper
• Alteration of Vesicle-Associated Membrane Protein-Binding Protein B in α-Synuclein Aggregates in Lewy Body Disease.

  2022cites this paper
• Alpha-synuclein supports type 1 interferon signalling in neurons and brain tissue.

  2022cites this paper
• Role of VAPB and vesicular profiles in α‐synuclein aggregates in multiple system atrophy

  2021cites this paper
• α-Synuclein A53T Binds to Transcriptional Adapter 2-Alpha and Blocks Histone H3 Acetylation

  2021cites this paper
• University of Southern Denmark Interaction between Parkin and α-Synuclein in PARK2-Mediated Parkinson's Disease

  2021cites this paper
• The biochemical basis of interactions between Glucocerebrosidase and alpha‐synuclein in GBA1 mutation carriers

  2020cites this paper
• Emerging pathways to neurodegeneration: Dissecting the critical molecular mechanisms in Alzheimer's disease, Parkinson's disease.

  2019cites this paper
• Dysfunction of Cellular Proteostasis in Parkinson’s Disease

  2019cites this paper
• Sumoylated α-synuclein translocates into the nucleus by karyopherin α6

  2018cites this paper
• GRK5 – A Functional Bridge Between Cardiovascular and Neurodegenerative Disorders

  2018cites this paper
• Reduced TH expression and α-synuclein accumulation contribute towards nigrostriatal dysfunction in experimental hepatic encephalopathy

  2017cites this paper
• Chromatin-Bound Oxidized α-Synuclein Causes Strand Breaks in Neuronal Genomes in in vitro Models of Parkinson’s Disease

  2017cites this paper
• Potential Role of Epigenetic Mechanism in Manganese Induced Neurotoxicity

  2016cites this paper
• Revista Española de Geriatría y Gerontología

  2016cites this paper
• Proaggregant nuclear factor(s) trigger rapid formation of α-synuclein aggregates in apoptotic neurons

  2016cites this paper
• Structure, function and toxicity of alpha‐synuclein: the Bermuda triangle in synucleinopathies

  2016cites this paper
• A Possible Mechanism for the Propagation of Pathological Proteins in Parkinson's Disease

  2015cites this paper
• Intracellular Dynamics of Synucleins: "Here, There and Everywhere".

  2015cites this paper
• Parkinson Disease Mutant E46K Enhances α-Synuclein Phosphorylation in Mammalian Cell Lines, in Yeast, and in Vivo*

  2015cites this paper
• Interaction between Neuromelanin and Alpha-Synuclein in Parkinson’s Disease

  2015cites this paper
• Altered machinery of protein synthesis is region- and stage-dependent and is associated with α-synuclein oligomers in Parkinson’s disease

  2015cites this paper
• Unregulated Lipid Peroxidation in Neurological Dysfunction

  2014cites this paper
• The nuclear accumulation of alpha-synuclein is mediated by importin alpha and promotes neurotoxicity by accelerating the cell cycle.

  2014cites this paper
• The role of lipid peroxidation in neurological disorders

  2014cites this paper
• Protein phosphorylation in neurodegeneration: friend or foe?

  2014cites this paper
• The novel Parkinson's disease linked mutation G51D attenuates in vitro aggregation and membrane binding of α-synuclein, and enhances its secretion and nuclear localization in cells.

  2014cites this paper
• α-Synuclein inclusions in the skin of Parkinson's disease and parkinsonism

  2014cites this paper
• Susceptibility of parkinson's disease following mild blast traumatic brain injury

  2014cites this paper
• Alpha-Synuclein Function and Dysfunction on Cellular Membranes

  2014cites this paper
• Immunolocalization of human alpha-synuclein in the Thy1-aSyn ("Line 61") transgenic mouse line.

  2014cites this paper
• 5‐S‐cysteinyldopamine neurotoxicity: Influence on the expression of α‐synuclein and ERp57 in cellular and animal models of Parkinson's disease

  2014cites this paper
• Nuclear translocation of alpha-synuclein increases susceptibility of MES23.5 cells to oxidative stress.

  2013influential citation
• [The role of extracellular α-synuclein in molecular mechanisms of cell death].

  2013cites this paper
• Limelight on Alpha-Synuclein: Pathological and Mechanistic Implications in Neurodegeneration

  2013cites this paper
• The Role of Oxidative Stress in Parkinson's Disease

  2013cites this paper
• Protein Truncation as a Common Denominator of Human Neurodegenerative Foldopathies

  2013cites this paper
• Toxicity of extracellular secreted alpha-synuclein: Its role in nitrosative stress and neurodegeneration.

  2013cites this paper
• Exercise-induced neuroprotection in a hemiparkinsonian 6-hydroxydopamine rat model

  2012cites this paper
• Alpha-synuclein in the neurodegenerative mechanisms of Parkinson's disease and dementia with Lewy bodies

  2012cites this paper
• Melatonin reduces the expression of alpha‐synuclein in the dopamine containing neuronal regions of amphetamine‐treated postnatal rats

  2012cites this paper
• A novel mechanism of non-Aβ component of Alzheimer's disease amyloid (NAC) neurotoxicity. Interplay between p53 protein and cyclin-dependent kinase 5 (Cdk5).

  2011cites this paper
• Papel de la genética en la etiología de las sinucleinopatías

  2011cites this paper
• Alpha-synuclein functions as a negative regulator for expression of tyrosine hydroxylase.

  2011cites this paper
• Nuclear Tau, a Key Player in Neuronal DNA Protection*

  2010cites this paper
• Protein-DNA Interaction at the Origin of Neurological Diseases: A Hypothesis

  2010cites this paper
• New evidences on Tau-DNA interactions and relevance to neurodegeneration.

  2010cites this paper
• Tau nucléaire : un acteur clé dans le stress neuronal

  2010cites this paper
• Ferroportin1 and hephaestin overexpression attenuate iron‐induced oxidative stress in MES23.5 dopaminergic cells

  2010influential citation
• Alpha-synuclein inhibits poly (ADP-ribose) polymerase-1 (PARP-1) activity via NO-dependent pathway.

  2009cites this paper
• Semi-quantitative analysis of alpha-synuclein in subcellular pools of rat brain neurons: an immunogold electron microscopic study using a C-terminal specific monoclonal antibody.

  2008cites this paper
• A possible physiological role of Abeta as a crosslinker

  2008cites this paper
• The Role of Alpha-Synuclein in Neurodegenerative Diseases: A Potential Target for New Treatment Strategies?

  2008cites this paper
• Cell systems and the toxic mechanism(s) of α-synuclein

  2008cites this paper
• Cell systems and the toxic mechanism(s) of alpha-synuclein.

  2008cites this paper
• Molecular and cellular biology of synucleins.

  2008cites this paper
• Mitochondrial translocation of alpha-synuclein is promoted by intracellular acidification.

  2008cites this paper
• Effect of α-synuclein on the promoter activity of tyrosine hydroxylase gene

  2007cites this paper
• Genetics of Parkinson's Disease

  2007cites this paper
• γ‐Synuclein and the progression of cancer

  2007cites this paper
• Effect of alpha-synuclein on the promoter activity of tyrosine hydroxylase gene.

  2007cites this paper
• Is alpha-synuclein pathology a target for treatment of neurodegenerative disorders?

  2007cites this paper
• Alpha‐synuclein protects cerebellar granule neurons against 6‐hydroxydopamine‐induced death

  2007influential citation
• Is alpha-synuclein pathology a target for treatment of neurodegenerative disorders?

  2007cites this paper
• Glial cell-derived neurotrophic factor protects against proteasome inhibition-induced dopamine neuron degeneration by suppression of endoplasmic reticulum stress and caspase-3 activation.

  2007cites this paper
• Gamma-synuclein and the progression of cancer.

  2007cites this paper